RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
RMFHX
Price
$56.13
Change
-$3.08 (-5.20%)
Updated
Dec 17 closing price
Ad is loading...

RMFCX vs RMFHX

Header iconRMFCX vs RMFHX Comparison
Open Charts RMFCX vs RMFHXBanner chart's image
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
American Funds American Mutual R5E
Price$56.13
Change-$3.08 (-5.20%)
VolumeN/A
CapitalizationN/A
RMFCX vs RMFHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. RMFHX commentary
Dec 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and RMFHX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX (104B) and RMFHX (104B) have equal amount of cash in the bank . RMFHX pays higher dividends than RMFCX: RMFHX (2.13) vs RMFCX (1.69). RMFCX was incepted earlier than RMFHX: RMFCX (23 years) vs RMFHX (9 years). RMFCX (25.00) and RMFHX (25.00) have comparable annual turnover. RMFCX (250) and RMFHX (250) have matching initial minimum investment requirements. RMFHX (13.09) and RMFCX (12.63) have marching annual gain over last year. RMFHX return over 5 years is better than : 44.00 vs. RMFCX (40.39).
RMFCXRMFHXRMFCX / RMFHX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years9 years-
Gain YTD11.42311.86696%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets104B104B100%
Annual Yield % from dividends1.692.1379%
Returns for 1 year12.6313.0996%
Returns for 3 years14.1615.8489%
Returns for 5 years40.3944.0092%
Returns for 10 years61.84N/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc